disease

Can ‘mini brains’ replace lab animals? Organoids are changing how scientists study disease

by Habib Rezanejad, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Three-dimensional organoids generated from mouse pancreatic ductal epithelial cells. Credit: Habib Rezanejad As a researcher, I still remember the discomfort I felt every time I had to sacrifice laboratory animals for an experiment. For decades, animals like […]

Can ‘mini brains’ replace lab animals? Organoids are changing how scientists study disease Read More »

This Common Issue Is Linked To 172 Diseases, According To A Large Study

A study from June 2025 suggested there’s one issue that’s clearly linked to a whopping 172 diseases. Perhaps even scarier, it’s a common one: disrupted sleep patterns. Researchers looked at more than 88,000 people’s data from the UK Biobank, a large-scale biomedical database in Britain, and found that poor sleep was associated with a higher risk of many conditions.

This Common Issue Is Linked To 172 Diseases, According To A Large Study Read More »

Are Your Patient’s Bad Dreams Predicting Disease?

Lisa Mulcahy January 07, 2026 Many clinicians will understandably dismiss a patient’s report of a vivid, frightening dream about falling ill as a byproduct of anxiety. However, a growing body of neurobiological research suggests these nocturnal narratives may be more than mere coincidence. Emerging evidence indicates that some dreams may serve as harbingers of disease,

Are Your Patient’s Bad Dreams Predicting Disease? Read More »

An AI tool is trying to predict your risk of getting many diseases years in advance— here’s how it works

by Natalia Levina, Hila Lifshitz-Assaf, João Sedoc, The Conversation edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes Datasets used to train AI algorithms may underrepresent older people. Credit: Pixabay/CC0 Public Domain Being able to instantly and accurately predict the trajectory of a person’s health in the years to come has long been seen as the pinnacle

An AI tool is trying to predict your risk of getting many diseases years in advance— here’s how it works Read More »

Experimental MS Drug Nearly Eliminates Disease Activity

PHOENIX — Frexalimab, a second-generation anti-CD40 ligand monoclonal antibody provides extended tight control of multiple sclerosis (MS) whether measured by relapse or brain imaging at 2-year follow-up, results of an open-label extension (OLE) of a phase 2 trial showed. “At week 96, there was almost complete suppression of new gadolinium-enhancing lesions with very similar pattern

Experimental MS Drug Nearly Eliminates Disease Activity Read More »

Scroll to Top